
|Articles|December 15, 2002
Accutane Goes Generic
The first generic version of Accutane (isotretinoin), approved Nov. 11 by the FDA, reached market in late November at a price approximately 5.5 percent lower than the brand name.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
How Emerging Androgenetic Alopecia Therapies Target DHT at the Scalp Level
2
Tildrakizumab Partially Reverses Epigenetic Aging in Psoriasis, Pilot Study Shows
3
Field-Directed Therapy Favored for Actinic Keratosis Management
4
From Biopsy to Biomarkers: Experts Navigate Skin Cancer Diagnosis and Staging
5





